The AI in Cancer Diagnosis Market is experiencing rapid growth, with a projected valuation of USD 845.78 billion by 2030. This is driven by the increasing adoption of advanced AI technologies for early detection and precise diagnosis of cancer. The market is segmented by component outlook, cancer type, end-user, and region, with the software solutions segment expected to dominate. Other key players in the market include Microsoft, Flatiron, and Kheiron Medical Technologies.
